NCT00822432View on ClinicalTrials.gov

Coproporphyrine Isomers and Methotrexate Elimination

CompletedOBSERVATIONAL
Enrollment

85

Participants

Timeline

Start Date

October 31, 2007

Primary Completion Date

August 31, 2011

Study Completion Date

August 31, 2011

Conditions
Central Nervous System NeoplasmsLymphoma, Large B-Cell, DiffusePrecursor B-Cell Lymphoblastic Leukemia-LymphomaBurkitt Lymphoma
Trial Locations (2)

37000

University Hospital Centre of Tours, Tours

75013

Pitié-Salpêtrière Hospital, Paris

All Listed Sponsors
lead

Assistance Publique - Hôpitaux de Paris

OTHER

NCT00822432 - Coproporphyrine Isomers and Methotrexate Elimination | Biotech Hunter | Biotech Hunter